194 related articles for article (PubMed ID: 11082114)
1. Inhibition of HERG1 K(+) channels by the novel second-generation antihistamine mizolastine.
Taglialatela M; Pannaccione A; Castaldo P; Giorgio G; Annunziato L
Br J Pharmacol; 2000 Nov; 131(6):1081-8. PubMed ID: 11082114
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines.
Taglialatela M; Pannaccione A; Castaldo P; Giorgio G; Zhou Z; January CT; Genovese A; Marone G; Annunziato L
Mol Pharmacol; 1998 Jul; 54(1):113-21. PubMed ID: 9658196
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs).
Taglialatela M; Secondo A; Fresi A; Rosati B; Pannaccione A; Castaldo P; Giorgio G; Wanke E; Annunziato L
Biochem Pharmacol; 2001 Nov; 62(9):1229-38. PubMed ID: 11705456
[TBL] [Abstract][Full Text] [Related]
4. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole.
Zhou Z; Vorperian VR; Gong Q; Zhang S; January CT
J Cardiovasc Electrophysiol; 1999 Jun; 10(6):836-43. PubMed ID: 10376921
[TBL] [Abstract][Full Text] [Related]
5. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole.
Suessbrich H; Waldegger S; Lang F; Busch AE
FEBS Lett; 1996 Apr; 385(1-2):77-80. PubMed ID: 8641472
[TBL] [Abstract][Full Text] [Related]
6. Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel.
Chachin M; Katayama Y; Yamada M; Horio Y; Ohmura T; Kitagawa H; Uchida S; Kurachi Y
Eur J Pharmacol; 1999 Jun; 374(3):457-60. PubMed ID: 10422790
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the K(+) channels encoded by the human ether-a-gogo-related gene-1 (hERG1) by nitric oxide.
Taglialatela M; Pannaccione A; Iossa S; Castaldo P; Annunziato L
Mol Pharmacol; 1999 Dec; 56(6):1298-308. PubMed ID: 10570058
[TBL] [Abstract][Full Text] [Related]
8. Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity.
Taglialatela M; Castaldo P; Pannaccione A; Giorgio G; Genovese A; Marone G; Annunziato L
Clin Exp Allergy; 1999 Jul; 29 Suppl 3():182-9. PubMed ID: 10444235
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological blockade of ERG K(+) channels and Ca(2+) influx through store-operated channels exerts opposite effects on intracellular Ca(2+) oscillations in pituitary GH(3) cells.
Secondo A; Taglialatela M; Cataldi M; Giorgio G; Valore M; Di Renzo G; Annunziato L
Mol Pharmacol; 2000 Nov; 58(5):1115-28. PubMed ID: 11040061
[TBL] [Abstract][Full Text] [Related]
10. Human ether-a-gogo related gene (HERG) K+ channels as pharmacological targets: present and future implications.
Taglialatela M; Castaldo P; Pannaccione A; Giorgio G; Annunziato L
Biochem Pharmacol; 1998 Jun; 55(11):1741-6. PubMed ID: 9714291
[TBL] [Abstract][Full Text] [Related]
11. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine.
Roy M; Dumaine R; Brown AM
Circulation; 1996 Aug; 94(4):817-23. PubMed ID: 8772706
[TBL] [Abstract][Full Text] [Related]
12. Expression of distinct ERG proteins in rat, mouse, and human heart. Relation to functional I(Kr) channels.
Pond AL; Scheve BK; Benedict AT; Petrecca K; Van Wagoner DR; Shrier A; Nerbonne JM
J Biol Chem; 2000 Feb; 275(8):5997-6006. PubMed ID: 10681594
[TBL] [Abstract][Full Text] [Related]
13. Of oocytes and runny noses.
Rosen MR
Circulation; 1996 Aug; 94(4):607-9. PubMed ID: 8772677
[No Abstract] [Full Text] [Related]
14. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
[TBL] [Abstract][Full Text] [Related]
15. Blockade of HERG and Kv1.5 by ketoconazole.
Dumaine R; Roy ML; Brown AM
J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
[TBL] [Abstract][Full Text] [Related]
16. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.
Ficker E; Obejero-Paz CA; Zhao S; Brown AM
J Biol Chem; 2002 Feb; 277(7):4989-98. PubMed ID: 11741928
[TBL] [Abstract][Full Text] [Related]
17. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
[TBL] [Abstract][Full Text] [Related]
18. Redox state dependency of HERGS631C channel pharmacology: relation to C-type inactivation.
Ulens C; Tytgat J
FEBS Lett; 2000 May; 474(1):111-5. PubMed ID: 10828461
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels.
Kiehn J; Thomas D; Karle CA; Schöls W; Kübler W
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):212-9. PubMed ID: 10208308
[TBL] [Abstract][Full Text] [Related]
20. Open channel block by KCB-328 [1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane hydrochloride] of the heterologously expressed human ether-a-go-go-related gene K+ channels.
Park JB; Choe H; Lee YK; Ha KC; Rhee KS; Ko JK; Joo CU; Chae SW; Kwak YG
J Pharmacol Exp Ther; 2002 Jul; 302(1):314-9. PubMed ID: 12065732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
